scispace - formally typeset
E

E. Cercenado

Researcher at Hospital General Universitario Gregorio Marañón

Publications -  60
Citations -  2084

E. Cercenado is an academic researcher from Hospital General Universitario Gregorio Marañón. The author has contributed to research in topics: Amikacin & Imipenem. The author has an hindex of 22, co-authored 60 publications receiving 1941 citations.

Papers
More filters
Journal ArticleDOI

Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa Isolates from Spanish Hospitals

TL;DR: Despite the currently low prevalence of epidemic clones with MDR, active surveillance is needed to detect and prevent the dissemination of these clones, particularly those producing integron- and plasmid-encoded MBLs, given their additional capacity for the intra- and interspecies spread of MDR.
Journal ArticleDOI

Metronidazole Resistance in Clostridium difficile Is Heterogeneous

TL;DR: Routine performance of the disk diffusion method with primary fresh C. difficile isolates is recommended to ensure that metronidazole-heteroresistant populations do not go undetected and prolonged exposure to metronidsazole can select for in vitro resistance.
Journal ArticleDOI

Role of Universal 16S rRNA Gene PCR and Sequencing in Diagnosis of Prosthetic Joint Infection

TL;DR: 16SPCR is more specific and has a better positive predictive value than culture for diagnosis of PJI, even when few samples are analyzed; however, culture is generally more sensitive.
Journal ArticleDOI

Pseudomonas aeruginosa: a Survey of Resistance in 136 Hospitals in Spain

TL;DR: The data on 1,014 isolates included resistance to the following antimicrobials: piperacillin-tazobactam, 7%; meropenem, 8%; amikacin, 9%; tobramycin, 10%; p Piperacillin, 10; ticarcillin, 13%; imipenem, 14%; ceftazidime, 15%; cefepime, 17%; ciprofloxacin; gentamicin.
Journal ArticleDOI

Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus.

TL;DR: It is suggested that mupirocin and co-trimoxazole plus fusidic acid, both used in conjunction with a chlorhexidine soap bath, are equally effective and safe for the eradication of MRSA from nasal and extranasal MRSA carriers.